We first studied ERα total protein levels by reanalyzing proteomics data from The Cancer Genome Atlas (TCGA) consortium (the prostate adenocarcinoma [PRAD] data set) (30, 31), with protein levels separated according to low versus high expression levels. The gene discussed is ESR1; the disease is prostate adenocarcinoma.